Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma

Published:1988-09-15 Issue:3 Volume:42 Page:329-338
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Fåhraeus Robin,Fu Hu Li,Ernberg Ingemar,Finke Jurgen,Rowe Martin,Klein George,Falk Kerstin,Nilsson Ethel,Yadav Manmohan,Busson Pierre,Tursz Thomas,Kallin Bengt

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference53 articles.

1. A putative transforming gene of jijoye virus differs from that of Epstein-Barr virus prototypes

2. , , and , The association between undifferentiated nasopharyngeal carcinoma and Epstein-Barr virus shown by correlated nucleic acid hybridization and histopathological studies. In: and (eds.), Nasopharyngeal carcinoma: etiology and control, pp. 347–357, IARC, Lyon (1978).

3. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells

4. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus.

5. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus

Cited by 420 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspecitve Chapter: Modulation of Latent to Lytic Cycle Infection Switch and its Implication in EBV Mediated Tumorigenicity;Epstein-Barr Virus - Emphasis on Molecular and Immunological Aspects [Working Title];2023-11-21

2. Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma;International Journal of Molecular Sciences;2023-06-14

3. EBV-Upregulated B7-H3 Inhibits NK cell–Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression;Cancer Immunology Research;2023-03-30

4. Epstein‑Barr virus‑associated lymphoepithelial carcinoma arising in the parotid gland: A case report and literature review;Molecular and Clinical Oncology;2023-02-10

5. EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models;Frontiers in Cellular and Infection Microbiology;2023-01-04